Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.49 |
| ▸ | GDA | Q9Y2T3 | 3/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | XDH | P47989 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.37 |
| ▸ | BLM | P54132 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.36 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Uric Acid SCHEMBL38665006 | 0.81 | MAPT (0.53) | MAPTADORA2BGDAACHEXDH | |
| SCHEMBL29737686 | 0.74 | MAPT (0.53) | MAPTADORA2BGDAACHEXDH | |
| Uric Acid SCHEMBL30269772 | 0.74 | MAPT (0.53) | MAPTADORA2BGDAACHEXDH | |
| SCHEMBL30728071 | 0.74 | MAPT (0.53) | MAPTADORA2BGDAACHEXDH | |
| SCHEMBL932949 | 0.74 | MAPT (0.53) | MAPTADORA2BGDAACHEXDH | |
| SCHEMBL740931 | 0.74 | MAPT (0.53) | MAPTADORA2BGDAACHEXDH | |
| SCHEMBL2837685 | 0.74 | MAPT (0.53) | MAPTADORA2BGDAACHEXDH | |
| Uric Acid SCHEMBL28407297 | 0.74 | MAPT (0.53) | MAPTADORA2BGDAACHEXDH | |
| SCHEMBL932609 | 0.74 | MAPT (0.53) | MAPTADORA2BGDAACHEXDH | |
| SCHEMBL30537976 | 0.74 | ALDH1A1 (0.60) | MAPTADORA2BGDAACHEXDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023185709-A1 | MARKER COMBINATION FOR DIAGNOSING ADVANCED COLORECTAL TUMOR, AND APPLICATION THEREOF | 武汉迈特维尔医学科技有限公司 | 2023-10-05 | — | — | WO | claimed |
| EP-0504040-B1 | Use of lactoferrin to protect hair keratin from atmospheric aggressions, particularly light, and process for protecting the hair using this compound | OREAL (FR) | 1995-06-14 | — | — | EP | claimed |
| EP-0504040-A1 | Use of lactoferrin to protect hair keratin from atmospheric aggressions, particularly light, and process for protecting the hair using this compound | L'OREAL (FR) | 1992-09-16 | — | — | EP | claimed |
| JP-5065214-A | — | — | None | — | — | JP | disclosed |
| EP-2968088-B1 | SUBSTANTIALLY SURFACTANT-FREE, SUBMICRON DISPERSIONS OF HYDROPHOBIC AGENTS CONTAINING HIGH LEVELS OF WATER MISCIBLE SOLVENT | LEADING EDGE INNOVATIONS LLC (US) | 2025-10-22 | — | — | EP | disclosed |
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | TEAM MEDICAL, LLC | 2025-09-18 | — | — | US | disclosed |
| US-12409111-B2 | System, method, and composition for skin improvement and transient flora reduction | Leading Edge Innovations, LLC (US) | 2025-09-09 | — | — | US | disclosed |
| US-12357546-B2 | Sprayable compositions containing oil-in-water emulsions containing submicron hydrophobic agents and methods of use thereof | Leading Edge Innovations, LLC (US) | 2025-07-15 | — | — | US | disclosed |
| US-12347524-B2 | Quantum mechanical X-ray crystallography and Cryo-EM diagnostic for molecules | QuantumBio Inc. (US) | 2025-07-01 | — | — | US | disclosed |
| WO-2024137539-A9 | SPRAYABLE COMPOSITIONS CONTAINING OIL-IN-WATER DISPERSIONS OF HYDROPHOBIC AGENTS AND POLYMER OR COPOLYMER FRAGMENTS, OR COMBINATIONS THEREOF | Leading Edge Innovations, LLC (US) | 2024-12-19 | — | — | WO | disclosed |
| WO-2024137566-A9 | SPRAYABLE SUNSCREEN COMPOSITIONS CONTAINING OIL-IN-WATER DISPERSIONS OF HYDROPHOBIC AGENTS AND POLYMER OR COPOLYMER FRAGMENTS, OR COMBINATIONS THEREOF, AND METHODS OF USE THEREOF | Leading Edge Innovations, LLC (US) | 2024-10-03 | — | — | WO | disclosed |
| CN-1240432-A | 1-phenylpyrazole compounds and medicinal application thereof | YOSHITOMI PHARMACEUTICAL (JP) | 2000-01-05 | — | — | CN | disclosed |
| CN-1215307-A | Compositions and methods for controlling insect pests | VIRGINIA TECH INTELL PROP (US) | 1999-04-28 | — | — | CN | disclosed |
| EP-0796099-A1 | USE OF XANTHINE OXIDASE INHIBITORS AS ANTI-ISCHAEMIC AGENTS | BTG INTERNATIONAL LIMITED (GB) | 1997-09-24 | — | — | EP | disclosed |
| EP-0504040-B1 | Use of lactoferrin to protect hair keratin from atmospheric aggressions, particularly light, and process for protecting the hair using this compound | OREAL (FR) | 1995-06-14 | — | — | EP | disclosed |
| JP-H0565214-A | COMPOSITION FOR PROTECTING HAIR FROM MECHANICAL DETERIORATION | L'OREAL SA | 1993-03-19 | — | — | JP | disclosed |
| EP-0504040-A1 | Use of lactoferrin to protect hair keratin from atmospheric aggressions, particularly light, and process for protecting the hair using this compound | L'OREAL (FR) | 1992-09-16 | — | — | EP | disclosed |
| EP-0504040-A1 | Use of lactoferrin to protect hair keratin from atmospheric aggressions, particularly light, and process for protecting the hair using this compound | L'OREAL (FR) | 1992-09-16 | — | — | EP | disclosed |
| CN-1014024-B | PROCESS FOR PREPARING PHARMACEUTICALS-FORMULATION | HOECHST AG (DE) | 1991-09-25 | — | — | CN | disclosed |
| CN-85106465-A | A kind of preparation process of pharmaceutical preparation | — | 1986-10-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12357546-B2 | Sprayable compositions containing oil-in-water emulsions containing submicron hydrophobic agents and methods of use thereof | LIPA, MGLL, SGMS2 | MAPT 1884/4885ADORA2B 2202/4885GDA 3717/4885 |
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | SYNCRIP, SNRPA, RNASE1 | MAPT 953/4885ADORA2B 583/4885GDA 488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.